27 October 2023
Australian Drug Trends 2023:
Key findings from the National Illicit Drug Reporting System (IDRS) Interviews
Key findings from the National Illicit Drug Reporting System (IDRS) Interviews
The Illicit Drug Reporting System (IDRS) is a national illicit drug monitoring system that has been conducted annually since 2000, and is part of Drug Trends. The IDRS interviews people who inject drugs (PWID) from every capital city of Australia and provides an analysis and examination of indicator data sources related to illicit drugs. It is designed to be sensitive to trends, providing data in a timely manner, rather than describing issues in detail.
The 2023 IDRS report provides the most up-to-date findings of the IDRS interviews from 2000 to 2023 with people who regularly inject illicit drugs.
This includes:
Results are not representative of all consumers or drug use in the general population and should be interpreted alongside findings from other data sources for a more complete profile of emerging trends in illicit drug use in Australia.
Latest release date
27 October 2023
Use of the data
Please note that any presentation of these data should include an acknowledgement of Drug Trends at the National Drug and Alcohol Research Centre, University of New South Wales.
Citation: Sutherland R, Uporova J, King C, Chandrasena U, Karlsson A, Jones F, Gibbs D, Price O, Dietze P, Lenton S, Salom C, Bruno R, Wilson J, Agramunt S, Daly C, Thomas N, Radke S, Stafford L, Degenhardt L, Farrell M, Peacock A. Australian Drug Trends 2023: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.
Funding
Drug Trends is supported by funding from the Australian Government Department of Health and Aged Care under the Drug and Alcohol Program.
Queries
Please contact the research team at drugtrends@unsw.edu.au with any queries; to request additional analyses using these data; or to discuss the possibility of including items in future IDRS interviews.
27 October 2023
Sutherland R, Uporova J, King C, Chandrasena U, Karlsson A, Jones F, Gibbs D, Price O, Dietze P, Lenton S, Salom C, Bruno R, Wilson J, Agramunt S, Daly C, Thomas N, Radke S, Stafford L, Degenhardt L, Farrell M, Peacock A.